Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Pathology-oriented, Prospective, Multicenter, Randomized, Open-label, Parallel Group Clinical Trial

NCT03415763 is registered in ClinicalTrials.gov with LI XIN-XIANG as lead sponsor.

NCT NCT03415763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03415763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Pathology-oriented, Prospective, Multicenter, Randomized, Open-label, Parallel Group Clinical Trial
Lead sponsor
LI XIN-XIANG
Phase
Phase 3
Overall status
Unknown status
Start date
November 5, 2018
Completion date
December 31, 2025
Enrollment
764 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal neoplasms